|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01681 CONSUN PHARMA
Nominal 
16.270 +0.370 (+2.327%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 1,568,588 | 23.652% | 1,268,549 | 1,119,679 | 993,528 | 886,526 |
| Cost of Sales | (359,907) | 12.111% | (321,026) | (283,263) | (255,437) | (225,286) |
| Gross Profit | 1,208,681 | 27.562% | 947,523 | 836,416 | 738,091 | 661,240 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (763) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 535,238 | 23.339% | 433,958 | 377,605 | 309,517 | 307,691 | |
| Taxation | (32,389) | -1.846% | (32,998) | (29,775) | (13,877) | (62,785) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (4,550) | 280.753% | (1,195) | 64 | 1,089 | 5,738 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 498,299 | 24.648% | 399,765 | 347,894 | 296,729 | 250,644 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (40,599) | 34.742% | (30,131) | (25,241) | (19,482) | (15,411) |
| Depreciation & Amortisation | 30,924 | -17.375% | 37,427 | 38,677 | 39,393 | 36,106 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 59.000 | 18.000% | 50.000 | 44.080 | 37.430 | 31.320 |
| DPS (cts) | 30.112 | -- | 27.466 | 13.755 | 0.000 | 8.317 |
| Dividend Payout Ratio (%) | 51.036% | -- | 54.932% | 31.205% | -- | 26.554% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 5.104 | -- | 4.383 | 4.068 | 3.419 | 2.872 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 498,299 |
| %Change | 24.648% |
| EPS / (LPS) | RMB 0.590 |
| NBV Per Share (¥) | RMB 5.104 |